Valuation (36%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 26,516.75 | 24.69 |
PEG Ratio (TTM) | -276.22 | 4.63 |
P/S Ratio (TTM) | 3.78 | 4.77 |
P/B Ratio (TTM) | 1.57 | -13.61 |
P/FCF Ratio (TTM) | 64.99 | 35.71 |
Price to 5YR AVG Earnings Ratio | 0.82 | 4.11 |
Price to 5YR AVG FCF Ratio | -8.44 | 72.94 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.00% | 6.52% |
ROE (TTM) | 0.01% | 162.26% |
Net Profit Margin (TTM) | 0.01% | 9.61% |
ROIC 5YR AVG | 3.95% | 10.57% |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -118.89% | -7.79% | -36.17% |
Revenue | 2.75% | 29.91% | 24.32% |
Net Income | -119.61% | 50.88% | -0.51% |
Cash Flow | 639.50% | 124.96% | 108.16% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.28 | 1.23 |
Quick Ratio (TTM) | 1.16 | 1.17 |
D/E Ratio (TTM) | 0.92 | -3.03 |
Interest Coverage (TTM) | 1.23 | 12.51 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 1.14 | 4.78 |
LTL to 5YR AVG FCF | -5.02 | 10.51 |
Shares Outstanding Growth 5YR AVG | 4,431.03% | 5.43% |